Pharmaceutical Licensing Insights

The Challenge of “Direct-to-Consumer” Pharma and TrumpRx

Alabama’s New Rule Has Massive DSCSA Implications on State Regulations

Puerto Rico Eliminates Special Authorization Licensing Requirement for All Non-Resident Entities

NABP DDA (VAWD) 2025 Pricing Changes Announced

Massachusetts Introduces Non-resident Pharmacy License

Puerto Rico: Virtual Manufacturer and Virtual Distributor License Applications Now Open

Automated Regulatory Updates with LighthouseAI

New NABP DDA (VAWD) Alternative Accreditation

Puerto Rico Suspends Controlled Substance Applications

FDA Grants Exemptions to Small Dispensers (Pharmacies) for Drug Tracing

Sterile Compounding Solves Semaglutide Access Problems

Kentucky Revisiting Licensing of Non-Registered Pharmacist

Connecticut Reporting Transparency Updates

The Current State of Xylazine

Navigating Puerto Rico's New Licensing Standards for Pharmaceutical Wholesale Distributors

1856 Regulatory Changes By Regulatory Agencies Since January 1st, 2024

New Mexico Passes Prescription Drug Price Transparency Act | Effective 01/01/2025

Supreme Court Ruling on Chevron Deference Threatens to Reshape the Regulatory Landscape